Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Scientific Reports|February 23, 2017
Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approachLei Chang, Jie Ni, Julia Beretov, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 18, 2020
Towards real time in-vivo rectal dosimetry during trans-rectal ultrasound based high dose rate prostate brachytherapy using MOSkin dosimetersJoel Poder, Andrew Howie, Ryan Brown, et al.
Frontiers in Oncology|April 20, 2019
Phase 2 Multicenter Study of Gantry-Based Stereotactic Radiotherapy Boost for Intermediate and High Risk Prostate Cancer (PROMETHEUS)David Pryor, Mark Sidhom, Sankar Arumugam, et al.
The International Journal of Biochemistry & Cell Biology|October 1, 2013
Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathwayJie Ni, Paul Cozzi, Jingli Hao, et al.
Oncotarget|October 7, 2016
Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapyJingli Hao, Peter Graham, Lei Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2023
Genitourinary Quality-of-Life Comparison Between Urethral Sparing Prostate Stereotactic Body Radiation Therapy Monotherapy and Virtual High-Dose-Rate Brachytherapy BoostMatthew Richardson, Mark Sidhom, Paul Keall, et al.
The Prostate|March 12, 2014
CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistanceJie Ni, Paul J Cozzi, Jing L Hao, et al.
Sensors (Basel, Switzerland)|January 26, 2024
Preliminary Characterization of an Active CMOS Pad Detector for Tracking and Dosimetry in HDR BrachytherapyThi Ngoc Hang Bui, Matthew Large, Joel Poder, et al.
Frontiers in Nutrition|March 24, 2023
Anti-cancer potential of synergistic phytochemical combinations is influenced by the genetic profile of prostate cancer cell linesCarol A Gano, Shadma Fatima, Timothy W Failes, et al.
European Urology Oncology|February 1, 2024
Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre TrialEric Wegener, Mark Sidhom, David Pryor, et al.
Pageof 7